By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MD Anderson Cancer Center 

500 Renaissance Drive

St. Joseph  Michigan  49085  U.S.A.
Phone: n/a Fax: n/a



Company News
Boston Strategics Corporation Enters Into An Innovative Risk-Sharing Agreement With MD Anderson Cancer Center To Conduct A Phase 1/2a Clinical Trial Of E6201 In Patients With Advanced Hematologic Malignancies Including Acute Myeloid Leukemia 12/17/2014 11:40:20 AM
MD Anderson Cancer Center Officials React To FDA Approval Of Gardasil 9 For The Prevention Of Certain Cancers 12/12/2014 8:13:52 AM
Manhattan Scientifics, Inc.’ Unparalleled Cancer Measurement Technology Featured In MD Anderson Cancer Center Presentation 10/8/2014 7:50:01 AM
Biocept, Inc. (BIOC) Expands Collaboration With MD Anderson Cancer Center 10/7/2014 7:51:08 AM
Bristol-Myers Squibb Company (BMY) And MD Anderson Cancer Center Announce Novel Research Collaboration In Immuno-Oncology Focused On Leukemia And Hematologic Malignancies 10/6/2014 8:24:14 AM
VolitionRX Announces Prostate Cancer Collaboration With The University of Texas MD Anderson Cancer Center 10/2/2014 9:10:57 AM
MD Anderson Cancer Center Department Chair Richard E. Champlin, M.D. Joins Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Iomab™-B Scientific Advisory Board 9/10/2014 10:10:54 AM
Research Study At Banner MD MD Anderson Cancer Center Tests New Drug To Fight BRCA-Associated Breast Cancer 8/20/2014 7:34:12 AM
Concord Medical Services Holdings Limited (CCM) Announces MD Anderson Cancer Center Proton Therapy Center Board Of Directors Meeting In Beijing 8/15/2014 8:35:49 AM
MD Anderson Cancer Center Postdoc Faked Results Of Novartis AG (NVS) Brain Tumor Study 8/1/2014 6:55:14 AM